INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "EXTENDED DOSING REGIMENS FOR ANTI-CD20 ANTIBODIES IN THE TREATMENT OF MULTIPLE SCLEROSIS"

GENEVA, April 19 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/EP2024/078440) for "EXTENDED DOSING REGIMENS FOR ANTI-CD20 ANTIBODIES IN THE TREATMENT OF MULTIPLE SCLEROSIS" on Oct 09, 2024. With publication no. WO/2025/078463, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GRAHAM, Gordon (Lichtstrasse 354056 Basel), KARLSSON, Goeril (Lichtstrasse 354056 Basel), MERSCHHEMKE, Martin (Lichtstrasse 354056 Basel), VOSTIAR, Igor (Im Langen Loh 2684054 Basel)

Abstract: The disclosure is directed ...